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Abstract
Background: Decreased levels of circulating bone marrow-derived progenitor cells have been associated with risk 
factors and cardiovascular diseases. Smoking is the most important modifiable risk factor for atherosclerosis in young 
women. The aim of this pilot study was to assess in healthy premenopausal women without other risk factors for 
cardiovascular disease the influence of nicotine abuse on the number of circulating progenitor cells in relation to 
endothelial function.
Methods: The number of endothelial progenitor cells, measured as colony-forming units in a cell-culture assay (EPC-
CFU) and the number of circulating CD34 + and CD34 + /CD133 + cells, measured by flow cytometry, was estimated in 
32 women at the menstrual phase of the menstrual cycle. In addition, flow-mediated dilation (FMD) was assessed as a 
marker for vascular function. In a subgroup of these women (n = 20), progenitor cells were also investigated at the mid-
follicular and luteal phases of the menstrual cycle.
Results: Compared to non-smokers, the abundance of circulating CD34 + cells was significantly lower in smoking 
women in the menstrual, mid-luteal, and mid-follicular phases of the menstrual cycle. The number of CD34 + 
progenitor cells was revealed to have significant positive correlation with FMD in young healthy women, whereas 
CD34 + /CD133 + progenitor cells and EPC-CFU showed no significant correlation.
Conclusion: The number of CD34 + progenitor cells positively correlates with FMD in young healthy women and is 
decreased by smoking.
Background
Vascular homeostasis is controlled not solely by cells of
the vessel wall, but also by circulating bone marrow-
derived progenitor cells (PCs). In particular, a subset of
circulating stem cells, designated endothelial progenitor
cells (EPCs), is considered to contribute to endothelial
cell regeneration and neovascularisation [1]. Levels of cir-
culating PCs/EPCs have been correlated with endothelial
function, atherogenic risk factors, as well as various car-
diovascular diseases [2-5]. Although prospective data are
still lacking, the number of PCs/EPCs is evidently
inversely related to cardiovascular risk [6,7].
Since a clear and generally accepted definition of EPCs
has until now not been established, most studies investi-
gating the nature and function of EPCs have focused on
flow-cytometric analysis of circulating cells that are posi-
tive for the haematopoietic stem cell markers CD34,
CD133 and for the vascular endothelial growth factor
receptor 2 (VEGFR2), and/or have concentrated on anal-
ysis of in vitro formation of colony-forming units (EPC-
CFU) [1,6]. There is some evidence that levels of circulat-
ing progenitor cells positive for CD34 (CD34 + cells) are
more strongly correlated with cardiovascular risk factors
than are progenitor cell populations with various combi-
nations of CD34, CD133, and VEGFR2 [6].
Women of reproductive age are exposed to lower car-
diovascular risk than are age-matched men [8]. This is
generally attributed to differences in sex hormones and,
* Correspondence: verena.stangl@charite.de
1 Med. Klinik mit Schwerpunkt Kardiologie und Angiologie, Charité - 
Universitaetsmedizin Berlin, Campus Mitte, Berlin, Germany
† Contributed equally
Full list of author information is available at the end of the articleLudwig et al. BMC Women's Health 2010, 10:20
http://www.biomedcentral.com/1472-6874/10/20
Page 2 of 8
specifically, to the protective cardiovascular properties of
female estrogens [9,10]. Notably, elevated estrogen
plasma concentrations in women correlate with higher
levels of circulating EPCs [11]. They accordingly promote
vascular repair and inhibit neointima formation after
carotid artery injury in mice [11]. The effects of estrogens
on EPCs are mediated by nitric oxide and antiapoptotic
mechanisms [11,12]. Changes in hormonal levels during
the menstrual cycle are likewise reflected in the number
of circulating progenitor cells. The highest levels of pro-
genitor cells positive for CD34 and CD133 (CD34 + /
CD133 +) were measured following the pre-ovulatory
phase: i.e., the cycle phase with the highest levels of estro-
gens [13-15].
Smoking is the most important modifiable risk factor
for atherosclerosis in young women [16]. The biological
mechanisms linking smoking and atherogenesis are com-
plex and not fully understood. In addition to inflamma-
tion, potential mechanisms by which smoking increases
the risk of cardiovascular diseases include systemic hae-
mostatic and coagulatory disturbances, lipid abnormali-
ties, increase in oxidative stress, and vascular endothelial
dysfunction [17-19]. It has been shown that smoking
attenuates the number of progenitor cells in the circula-
tory system of male individuals, and that smoking cessa-
tion leads to a rapid elevation in progenitor cell levels
[20]. It is presently unknown whether there is a link
between smoking and the amount of progenitor cells in
women in which endogenously released estrogens may
further influence progenitor cell levels.
The aim of the present study was accordingly to investi-
gate whether smoking influences the number of progeni-
tor cells in young healthy women without other
cardiovascular risk factors, and whether there is correla-
tion between the amount of progenitor cells and endothe-
lial function assessed as flow-mediated dilation (FMD) of
the brachial artery.
Methods
Study population
Non-smoking and smoking women aged 25 to 35 years
were recruited by press advertisements. Subjects with
chronic diseases or known cardiovascular risk factors
other than smoking were excluded. All women had regu-
lar menstrual cycles and had not taken medication for
more than 3 months before study entry. The admitted
non-smoking women had never smoked, and smoking
women were required to have smoked at least 15 ciga-
rettes/day for at least one year. Women were invited for
preliminary examinations during the luteal phase at day
M-7 of the previous menstrual cycle (day 1 is the first day
of menstrual bleeding [M] of the expected following
menstrual period). All values for clinical parameters were
required to lie within the normal range to allow study
inclusion: lipid profile including lipoprotein (a), blood
pressure, body mass index, as well as routine internal and
endocrine parameters. Serum progesterone was required
to be > 18 nmol/L as a marker of an ovulatory menstrual
cycle. The study protocol was approved by the Human
Research Committee of the institution and conforms to
the principles outlined in the Declaration of Helsinki. All
subjects gave written informed consent.
Study design
All volunteers underwent a clinical examination at the
menstrual phase of the menstrual cycle (M + 3; day 3
after first day of menstrual bleeding). Blood from the
antecubital vein was collected at 8.00 a.m. after a 12-hour
overnight fast. The samples were centrifuged and stored
at -70 °C until chemical analysis. For analysis of progeni-
tor cells, blood was collected in EDTA vials and pro-
cessed immediately. Endothelial function was measured
by high-resolution vascular ultrasound. To assess the rel-
evance of cyclical hormonal changes on progenitor cells,
levels of these cells were additionally investigated in a
subgroup of women at mid-follicular (M + 7; day 7 after
first day of menstrual bleeding) and at mid-luteal (M-7)
phases of the menstrual cycle. In this subgroup at M-7,
the required minimum limit for progesterone was 18
nmol/L; otherwise the data were excluded from the anal-
yses.
EPC culture assay
Peripheral blood monocytic cells (PBMCs) were isolated
from 18 ml of whole blood by density-gradient centrifu-
gation with Ficoll-Paque™ (Amersham Pharmacia). Cells
were plated in M199 medium (GIBCO 31153) with sup-
plements (100 U/L penicillin, 100 μg/ml streptomycin,
20% fetal calf serum) on fibronectin-coated 24-well plates
with a density of 1-106 cells per well. Nonadherent cells
were removed after 3 days of culture, and colony forming
units (CFU) were counted under light microscope on day
7 (6 wells per measuring point). Confirmation of
endothelial like cell type was performed using the uptake
of DiI-acetylated low density lipoprotein (acLDL-DiI) as
indicator. Selected samples were positively tested for the
expression of CD31 and endothelial nitric oxide synthase
and for the formation of three dimensional tube struc-
tures in matrigel. Numbers of EPC were calculated as
"EPC-CFU per 1 × 106 PBMCs".
Flow cytometry
Whole blood (0.5 ml) was stained with conjugated anti-
bodies anti-CD34-APC (BD Pharmingen) and anti-
CD133-PE (Miltenyi). Erythrocytes were subsequently
lysed with EasyLyse Solution (Dako). Then the samples
were washed with buffer containing phosphate-buffered
saline and 0.5% bovine albumin. The numbers of circulat-Ludwig et al. BMC Women's Health 2010, 10:20
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ing progenitor cells (CD34 + and CD34 + /CD133 +) were
evaluated by flow cytometry (CyAn-ADP, Beckman-
Coulter) as follows: The mononuclear cell fraction was
identified by their low side scatter. Cells positive for
CD34 were gated and examined for additional expression
of CD133 (Figure 1A). Fluorescence-labeled, isotype-
matched nonspecific immunoglobulin G antibodies
served as controls for nonspecific staining. All instru-
ment settings and the measurement procedure were
stored in a protocol file and remained unchanged
throughout the analyses. The gate on the mononuclear
cell populations was set individually for each sample, and
5 × 105 PBMCs were measured. The concentrations of
progenitor cells were calculated as "progenitor cells %
PBMCs".
Measurement of FMD and NMD
Endothelial function was measured by high-resolution
vascular ultrasound with a 13-MHz linear array trans-
ducer (Sonoline Antares, Siemens), as recently described
[21]. Briefly, endothelium-dependent FMD was assessed
by measuring the change in brachial artery diameter after
reactive hyperaemia for 2 minutes, according to estab-
lished guidelines [22,23]. Endothelium-independent
nitro-mediated dilation (NMD) was measured after sub-
lingual application of nitro-glycerine spray (0.4 mg) for 6
minutes. FMD and NMD were defined as the maximum
change in brachial artery diameter, in percent, compared
to baseline measurement. Analyses of diameter changes
were conducted offline (Tom Tec Imaging Systems) by
two blinded investigators.
Statistics
Values in tables and text are presented as mean ± stan-
dard deviation, and in the figures as mean ± SEM. All sta-
tistical tests were two-sided (level of significance = 0.05).
Values with normal distribution were analysed by para-
metric tests. For comparisons of clinical parameters,
which are not normally distributed, nonparametric rank-
sum tests were used (paired Wilcoxon test, Mann-Whit-
ney test). Correlations are given by the Spearman rank
correlation coefficient. A linear regression analysis was
performed to test the effect of adjusted age and smoking
status on progenitor cells. The statistical model used for
evaluation of the variables CD34 +, CD34 + /CD133 +
and EPC-CFU over time (menstrual cycle) was a linear
Figure 1 Enumeration of circulating progenitor cells. A) Detection of CD34 + side scatterlow and CD34 + /CD133 + side scatterlow cells, defining 
circulating progenitor cells, by flow cytometry. B) Endothelial progenitor cells analyzed by in vitro formation of colony forming unit (EPC-CFU) in a cell 
culture assay of peripheral blood mononuclear cells of young healthy women. Phase contrast photomicrograph of endothelial progenitor cell colony 
(EPC-CFU) with a central cluster of cells surrounded by migratory spindle shaped cells (left) and fluorescence photomicrograph after staining with 
acLDL-Dil (right).Ludwig et al. BMC Women's Health 2010, 10:20
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mixed model with fixed and random effects. The analyses
were performed with Software SPSS version 16.0 and R
version 2.6.2.
Results
Baseline characteristics
As described in Table 1, the study population consisted of
32 healthy women (mean age 31.3 ± 3.2 years) without
overweight, hypertension, dyslipidemia including lipo-
protein (a) diabetes, hyperhomocysteinemia, or family
history of cardiovascular diseases. Nicotine abuse was the
only cardiovascular risk factor established for 17 women
within the study population. Smoking women were
slightly older (32.4 ± 2.9 vs. 29.7 ± 2.9 years, p < 0.05). No
other parameters showed significant differences between
the two groups. Menstrual cycle was of normal length
(mean cycle length 28.7 ± 2.1 days). Women of the sub-
group that was additionally investigated at mid-follicular
and luteal phases of the menstrual cycle (n = 20) showed
the typical cyclical pattern in the concentrations of sexual
steroids.
Effect of smoking on the number of circulating progenitor 
cells in young healthy women
At menstrual phase (M + 3; day 3 after first day of men-
strual bleeding) in the 17 smoking women, we found an
abundance of CD34 + cells that was significantly lower
than among the 15 non-smoking women (0.06 ± 0.02 vs.
0.10 ± 0.03% of PMBC, p = 0.01). The CD34 + /CD133 +
progenitor cell number was also lower in smoking
women, close to significance (p = 0.056). The numbers
are in the expected range when compared to studies using
similar evaluation methods [24,25].
The mean value of EPC-CFU was clearly lower for
smoking than for non-smoking women (18.8 ± 18.6 vs.
36.5 ± 34.0 per 106 PBMC). However, due to extensive
variations within the groups, the difference is not statisti-
cally significant (Figure 2). In a similar manner, FMD was
slightly but not significantly reduced in smoking women.
NMD did not show significant differences in the two
groups. All results are presented in detail in Table 2.
We next analyzed the number of progenitor cells in the
subgroup of women investigated at luteal and follicular
Table 1: Baseline characteristics of the study group (n = 32)
Whole group
(n = 32)
Non-smokers
(n = 15)
Smokers
(n = 17)
Age* (years) 31.3 ± 3.2 29.7 ± 2.9 32.4 ± 2.9
BMI (kg/m2) 21.3 ± 1.5 21.3 ± 1.7 21.3 ± 1.4
Cycle length (days) 28.7 ± 2.1 29 ± 2.2 28.5 ± 1.5
Nicotine abuse (pack years) - - 14.8 ± 4.6
RR syst (mmHg) 98 ± 33 102 ± 30 94 ± 36
RR diast (mmHg) 65 ± 22 67 ± 20 63 ± 25
Total cholesterol (mg/dl) 164 ± 23 158 ± 17 168 ± 27
HDL (mg/dl) 64.4 ± 10.1 66.9 ± 9.1 62.2 ± 10.7
LDL (mg/dl) 85.8 ± 24.5 79.9 ± 16.5 91.1 ± 29.4
Triglyceride (mg/dl) 67.7 ± 28.4 57.5 ± 13.4 76.7 ± 35.0
Lipoprotein(a) (mg/dl) 7.0 ± 4.0 7.4 ± 4.2 6.6 ± 3.8
hsCrP (mg/dl) 0.08 ± 0.07 0.09 ± 0.08 0.08 ± 0.06
Insulin (mIU/l) 5.6 ± 2.2 5.2 ± 2.1 6.0 ± 2.3
Glucose (mg/dl) 87.7 ± 7.2 87.0 ± 4.9 88.4 ± 8.8
Homocystein (μmol/l) 8.5 ± 1.7 8.2 ± 1.7 8.7 ± 1.8
Folic acid (μg/l) 8.8 ± 4.5 10.2 ± 5.6 7.6 ± 2.8
Uric acid (μmol/l) 3.9 ± 0.9 3.7 ± 0.9 4.1 ± 0.8
Estradiol (pmol/l) 613 ± 194 598 ± 191 626 ± 201
Progesterone (nmol/l) 51.4 ± 17.6 51.2 ± 16.4 51.5 ± 19.2
LH (IU/l) 4.7 ± 2.9 4.5 ± 3.8 4.9 ± 2.0
FSH (IU/l) 2.7 ± 1.2 2.8 ± 1.5 2.7 ± 0.7
*p < 0.05 for comparison of non-smokers with smokers; values are mean ± SD;
BMI = body mass index; LH = luteinising hormone; FSH = follicle stimulating hormone; RR syst = systolic blood pressure; RR diast = diastolic 
blood pressure; HDL = high-density lipoprotein; LDL = low-density lipoprotein; hsCrP = high-sensitivity C-reactive protein.Ludwig et al. BMC Women's Health 2010, 10:20
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phases of the menstrual cycle. Results are summarized in
Table 3. Only women with an ovulatory menstrual cycle
were included in this subgroup (n = 20). Concentration of
sexual steroids showed the typical cyclical pattern, with
significantly higher levels of estradiol and progesterone at
mid-luteal phase than in the menstrual and mid-follicular
phases (8 non-smoking women, 12 smoking women).
Neither the number of CD34 + and CD34 + /CD133 +
progenitor cells nor the number of EPC-CFU showed sig-
nificant differences between the three investigated time
points of the menstrual cycle. However, in correlation
with results found at the menstrual phase, CD34 + cell
levels were significantly lower in smoking than in non-
smoking women at mid-follicular and mid-luteal phases.
The numbers of EPC-CFU showed a non-significant
trend towards lower values in smoking women, whereas
CD34 + /CD133 + progenitor cell counts were not influ-
enced by smoking in this subgroup (Table 3).
Number of circulating CD34 + cells in young healthy 
women correlates with endothelial function
We examined women at menstruation, the cycle phase
with lowest concentrations of sexual steroids. Levels of
EPC-CFU showed broad interindividual distribution (0.7
to 118.3 cells per 106 per PBMCs). Levels of circulating
progenitor cells estimated by flow cytometry ranged from
0.03% to 0.145% and 0.02% to 0.10% of PBMCs for CD34
+ and CD34 + /CD133 + progenitor cells, respectively.
The number of CD34 + progenitor cells revealed a signif-
icant positive correlation with FMD (r = 0.435, p = 0.014)
(Figure 3). Levels of CD34 + /CD133 + progenitor cells
and of EPC-CFU, however, showed no correlation with
FMD. NMD likewise failed to correlate with the number
of CD34 + cells, CD34 + /CD133 + cells, or EPC-CFU.
Adjustment of FMD, number of CD 34 + cells, and num-
ber of CD34 + /CD133 + cells for age did not disclose an
influence of this variable.
Discussion
The major observation of the present study is that levels
of circulating progenitor cells and endothelial progenitor
cells are decreased in healthy young women with chronic
nicotine abuse. In addition, the number of CD34 + pro-
genitor cells positively correlates with endothelial func-
tion assessed as flow-mediated dilation of the brachial
artery.
Previous studies have shown that chronic nicotine
abuse leads to a decrease in circulating progenitor cell
levels in men [20]. Two hypotheses have been discussed
to explain underlying mechanisms: First, smoking-related
ROS production may decrease the bioavailability of nitric
oxide (NO), thereby reducing mobilization of PCs from
the bone marrow [26,27]. Second, smoking leads to
endothelial dysfunction, and injured vessels may use PCs
Figure 2 Influence of smoking on the number of circulating pro-
genitor cells. A) CD34 + and CD34 + /CD133 + cell populations in pe-
ripheral blood measured by flow cytometry. Level of circulating CD34 
+ progenitor cells is significantly decreased by smoking in young 
healthy women. B) Endothelial progenitor cells analyzed by in vitro for-
mation of colony forming unit (EPC-CFU) in a cell culture assay of pe-
ripheral blood mononuclear cells. Number of EPC-CFU is decreased by 
smoking in young healthy women. *p < 0.05 for comparison of non-
smokers with smokers; values are mean ± SEM.
Table 2: Summary of results for M + 3
Whole group
(n = 32)
Non-smokers
(n = 15)
Smokers
(n = 17)
CD34+ (% of PMBC) 0.08 ± 0.03 0.10 ± 0.03 0.06 ± 0.02*
CD34+/CD133+ (% of PMBC) 0.04 ± 0.02 0.05 ± 0.02 0.04 ± 0.01
EPC-CFU (per 106 PBMC) 27.1 ± 28.0 36.5 ± 34.0 18.8 ± 18.6
FMD (%) 9.2 ± 4.1 9.9 ± 4.5% 8.5 ± 3.7
NMD (%) 25.0 ± 7.3 24.3 ± 7.2 25.7 ± 7.5
Estradiol (pmol/l) 151 ± 75 175 ± 76 130 ± 70
Progesterone (nmol/l) 3.86 ± 1.54 3.12 ± 1.29 4.5 ± 1.48
*p < 0.05 for comparison of non-smokers with smokers; values are mean ± SD; CD34+ = progenitor cells positive for haematopoietic stem cell 
marker CD34; CD34+/CD133+ = progenitor cells positive for hematopoietic stem cell markers CD34 and CD133; EPC-CFU = endothelial 
progenitor cells analyzed by in vitro formation of colony forming unit; FMD = flow-mediated dilation; NMD = nitro-mediated dilationLudwig et al. BMC Women's Health 2010, 10:20
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to maintain endothelial function [20]. An imbalance of
injury and repair of vasculature promotes the progression
of atherosclerosis, and reduced PC levels may be a
marker of such an imbalance caused by smoking [27].
PCs are known to be upregulated by estrogens through
inhibition of apoptosis, stimulation of telomerase, and
bone marrow mobilization [11,28,29]. Fertile women
have higher levels of PCs than do age-matched men; after
menopause, levels of PCs no longer evidence sex-specific
differences [14]. Higher PC levels in fertile women have
been suggested to contribute to the lower cardiovascular
risk compared to men. In order to explain the effect of
smoking and the estrogen status on progenitor cell and
EPC-CFU content, we first examined women at menstru-
ation, the cycle phase with lowest concentrations of sex-
ual steroids. We established a significant decrease of
CD34 + progenitor cells in smoking women. Importantly
- in a cross-analysis of six different progenitor cell sub-
types characterized by different combinations of the sur-
face markers CD34, CD133, and VEGFR2 - it had been
previously shown that the abundance of the progenitor
cell population with CD34 + alone revealed the best cor-
relation with cardiovascular parameters and risk esti-
mates [6]. Concordantly, we found a positive correlation
of levels of CD34 + cells with endothelial function in
young healthy women. These data concur with other
studies describing a positive correlation between FMD
and PCs: which emphasizes the close relationship of these
two markers in reflection of vascular homeostasis [6,14].
It is well established that cigarette smoking is sufficient
to impair endothelial function in healthy adults [18,30].
Although hormonal cycle-dependent changes of
endothelial function are relevant in premenopausal
women, most clinical studies of the effects of smoking on
endothelial-dependent vasodilation have not considered
menstrual cycle phases in women. We have recently
shown that there are no significant differences in
endothelial function between smoking and non-smoking
women at menstruation [31]. Consequently, the results of
the present study support the conclusion that chronic
smoking affects the level of CD34 + progenitor cells
before manifestation of endothelial dysfunction in
healthy young women. It has been suggested that oxida-
tive stress and decreased availability of NO are causative
for endothelial dysfunction induced by smoking [32,33].
Since there is evidence that NO is necessary for PC mobi-
lization and function [26,27,34], NO deficiency may be a
key factor resulting in the PC decrease in young smoking
women. W e suggest, that deficient mobilization of PCs
due to limited NO availability caused by smoking pre-
cedes detectable alterations of endothelial function and in
this sense may represent a sensitive, early parameter of
cardiovascular risk. Clearly, this should be an important
consideration for future studies.
Table 3: Levels of progenitor cells during the menstrual cycle
non-smokers
(n = 8)
Smokers
(n = 12)
M + 3 M + 7 M - 7 M + 3 M + 7 M - 7
CD34+ (%PMBC) 0.08 ± 0.03 0.09 ± 0.03 0.08 ± 0.02 0.06 ± 0.02* 0.06 ± 0.02* 0.06 ± 0.01*
CD34+/CD133+ (%PMBC) 0.04 ± 0.02 0.04 ± 0.02 0.04 ± 0.02 0.04 ± 0.01 0.02 ± 0.01 0.03 ± 0.01
EPC-CFU (per106 PBMC) 45.8 ± 12.5 49.3 ± 22 28.2 ± 6.4 21.9 ± 18.8 14.5 ± 21.3 16.4 ± 19.1
estradiol (pmol/l) 188 ± 79 353 ± 119 664 ± 138 138 ± 78 285 ± 150 545 ± 128
progesterone (nmol/l) 2.6 ± 0.6 1.7 ± 0.4 55.3 ± 26.9 4.8 ± 1.6 2.8 ± 0.8 47.1 ± 16.8
*p < 0.05 for comparison of non-smokers vs. smokers; values are mean ± SD; CD34+ = progenitor cells positive for hematopoietic stem cell 
marker CD34; CD34+/CD133+ = progenitor cells positive for hematopoietic stem cell markers CD34 and CD133; EPC-CFU = endothelial 
progenitor cells analyzed in vitro by formation of colony forming units
Figure 3 Relation between the number of circulating CD34 + pro-
genitor cells and endothelial function. Measured as flow-mediated 
dilation (FMD) in the brachial artery in young healthy women.Ludwig et al. BMC Women's Health 2010, 10:20
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Investigations of the influence of nicotine abuse on PC
levels in premenopausal women should in fact consider
hormonal fluctuations during the menstrual cycle. In our
study, however, we found no significant differences in the
amount of progenitor cells between follicular and luteal
phases of the menstrual cycle, despite an increase in
estrogen levels. These results concur with previous stud-
ies showing significant periovulatory increase of progeni-
tor cells, but no differences between follicular and luteal
phases [13-15]. It is interesting to note that the differ-
ences in levels of CD34 + cells between smoking and non-
smoking women were maintained in all three phases,
independently of the estrogen status.
There are some limitations in the present study. In con-
junction with the small sample size, smoking women
were somewhat older than non-smoking. It cannot be
ruled out that older age in smoking women contributes to
decreased numbers of progenitor cells. However, adjust-
ment of progenitor cell number and FMD values in a lin-
ear regression analysis did not show an influence of age
differences on our study results.
Conclusion
The number of CD34 + progenitor cells positively corre-
lates with FMD in young healthy women and is decreased
by smoking.
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